Literature DB >> 8332194

Complementation of byr1 in fission yeast by mammalian MAP kinase kinase requires coexpression of Raf kinase.

D A Hughes1, A Ashworth, C J Marshall.   

Abstract

Intracellular signalling from receptor tyrosine kinases in mammalian cells involves the activation of a signal cascade which includes p21ras and the protein kinases p74raf-1, MAP kinase kinase and MAP kinases. In the yeasts Schizosaccharomyces pombe and Saccharomyces cerevisiae the response to mating pheromones requires the Spk1 and KSS1/FUS3 kinases, which have sequence homology to vertebrate MAP kinases. The recent cloning of complementary DNAs for mammalian and frog MAP kinase kinases has shown that they are homologous to the S. pombe Byr1 (ref. 17) and S. cerevisiae STE7 (ref. 18) kinases, which have been proposed to function upstream of Spk1 and KSS1/FUS3, respectively. We have investigated whether these apparently similar kinase pathways are functionally conserved between vertebrates and S. pombe. We report here that expression of mammalian MAP kinase kinase alone fails to complement a byr1 mutant of S. pombe. When coexpressed with Raf kinase, however, MAP kinase kinase is activated by phosphorylation and the mating defect of the byr1 mutant is rescued. This suggests that the pathways are functionally homologous and that Raf kinase may directly phosphorylate and activate MAP kinase kinase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8332194     DOI: 10.1038/364349a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  18 in total

1.  Spm1, a stress-activated MAP kinase that regulates morphogenesis in S.pombe.

Authors:  T Zaitsevskaya-Carter; J A Cooper
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 2.  The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors.

Authors:  K Malarkey; C M Belham; A Paul; A Graham; A McLees; P H Scott; R Plevin
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

3.  Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.

Authors:  M Tanaka; R Gupta; B J Mayer
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

4.  Direct binding and In vivo regulation of the fission yeast p21-activated kinase shk1 by the SH3 domain protein scd2.

Authors:  E Chang; G Bartholomeusz; R Pimental; J Chen; H Lai; L h Wang; P Yang; S Marcus
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

5.  Schizosaccharomyces pombe map1+ encodes a MADS-box-family protein required for cell-type-specific gene expression.

Authors:  N Yabana; M Yamamoto
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

6.  Shk1, a homolog of the Saccharomyces cerevisiae Ste20 and mammalian p65PAK protein kinases, is a component of a Ras/Cdc42 signaling module in the fission yeast Schizosaccharomyces pombe.

Authors:  S Marcus; A Polverino; E Chang; D Robbins; M H Cobb; M H Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

7.  Cloning and characterization of p97MAPK, a novel human homolog of rat ERK-3.

Authors:  A X Zhu; Y Zhao; D E Moller; J S Flier
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Mammalian mitogen-activated protein kinase kinase kinase (MEKK) can function in a yeast mitogen-activated protein kinase pathway downstream of protein kinase C.

Authors:  K J Blumer; G L Johnson; C A Lange-Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  Raf-1 protein expression in human breast cancer cells.

Authors:  L S Callans; H Naama; M Khandelwal; R Plotkin; L Jardines
Journal:  Ann Surg Oncol       Date:  1995-01       Impact factor: 5.344

Review 10.  Signal transduction pathways involving the Raf proto-oncogene.

Authors:  N G Williams; T M Roberts
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.